Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bacteroides fragilis septicemia].

J L Blache, F Gouin, Y Peloux

    Annales De L'Anesthesiologie Francaise
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Improved nationwide survival of sarcoma patients with a network of reference centers.

    Annals of oncology : official journal of the European Society for Medical Oncology·2024
    Same author

    Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.

    European journal of cancer (Oxford, England : 1990)·2023
    Same author

    Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years.

    European journal of cancer (Oxford, England : 1990)·2023
    Same author

    Corrigendum to "SELNET clinical practice guidelines for soft tissue sarcoma and GIST" [Cancer Treat. Rev. 102 (2021) 102312].

    Cancer treatment reviews·2023
    Same author

    Corrigendum to "SELNET clinical practice guidelines for bone sarcoma" Critical reviews in oncology/hematology, vol. 174 (2022), 1-10.

    Critical reviews in oncology/hematology·2022
    Same author

    SELNET clinical practice guidelines for bone sarcoma.

    Critical reviews in oncology/hematology·2022
    Same journal

    [Study of cellular immunity by the nuclear refringence test during general anesthesia].

    Annales de l'anesthesiologie francaise·1981
    Same journal

    [Pharmacology of fazadinium (AH 8165)].

    Annales de l'anesthesiologie francaise·1981
    Same journal

    [Pharmacology of dobutamine].

    Annales de l'anesthesiologie francaise·1981
    Same journal

    [Bacterial resistance to antibiotics].

    Annales de l'anesthesiologie francaise·1981
    Same journal

    [Management of a multi-injured patient with severe closed chest injuries].

    Annales de l'anesthesiologie francaise·1981
    Same journal

    [Preoperative nutritional state in 40 patients with digestive cancer. Effect of surgery and two different protocols for parenteral nutrition].

    Annales de l'anesthesiologie francaise·1981
    See all related articles

    Bacteroides fragilis septicaemia is increasingly common, often originating from surgical sites or postpartum conditions. Metronidazole and tinidazole are effective treatments, with potential for preventive use in high-risk patients.

    Area of Science:

    • Infectious Diseases
    • Microbiology
    • Clinical Medicine

    Context:

    • Bacteroides fragilis is an increasingly prevalent cause of septicaemia.
    • Common entry points include localized suppuration post-surgery (digestive, gynecological) and postpartum/post-abortion periods.
    • Septicemia cases attributed to B. fragilis are rising, now representing approximately 10% of all septicemias.

    Purpose:

    • To review recent literature on Bacteroides fragilis septicaemia.
    • To highlight the increasing prevalence and common sources of infection.
    • To discuss current therapeutic strategies and their efficacy.

    Summary:

    • The study reviews eight cases of Bacteroides fragilis septicaemia and relevant literature.
    • Identifies digestive/gynecological surgery and postpartum periods as frequent infection origins.

    Related Experiment Videos

  • Emphasizes imidazole derivatives (metronidazole, tinidazole) as highly effective treatments.

    • Impact:

    • Informs clinicians about the rising incidence of B. fragilis septicaemia.
    • Guides therapeutic choices towards imidazole derivatives for effective treatment.
    • Suggests potential for prophylactic use of antibiotics in high-risk individuals.